American Society for Histocompatibility and Immunogenetics

News > EFI 2015 early bird registration deadline - Monday, March 16th

EFI 2015 early bird registration deadline - Monday, March 16th

Don't forget that the early bird deadline to register for EFI 2015 is Monday March 16th. To register, please click hereRemember, ASHI members are eligible to register at the EFI member rate!
 
See you in Geneva!
 
Best regards,
EFI Congress Secretariat

OPTN Policy Requirements for Informed Consent & Psychosocial & Medical Evaluation for Living Donors | ASHI

News > OPTN Policy Requirements for Informed Consent & Psychosocial & Medical Evaluation for Living Donors

OPTN Policy Requirements for Informed Consent & Psychosocial & Medical Evaluation for Living Donors

UNOS provided information about a new OPTN Policy Requirements for Informed Consent and Psychosocial and Medical Evaluation for Living Donors recording and learning pathway. The recording is approximately 25 minutes long and can be accessed at: https://attendee.gotowebinar.com/recording/782902120732866817

 

After viewing the recording, access the evaluation and assessment via the following link: https://www.surveymonkey.com/s/LDICPME.For those interested in receiving credit for participation, ABTC will award 0.5 Category 1 CEPTC credit. To receive credit, you must pass the assessment. The assessment may be taken more than once. If you do not wish to receive CEPTC credit, taking the assessment is not necessary.

 

Once you passed the assessment, your certificate will be e-mailed to you in four to six weeks. CEPTCs are available until July 15, 2015.

 

The pathway is located on the OPTN website at: http://optn.transplant.hrsa.gov/news/new-policy-requirements-for-living-donor-informed-consent-and-evaluations/ and Transplant Pro at: http://transplantpro.org/new-policy-requirements-living-donor-informed-consent-evaluations/.

 

If there are questions, please contact:

 

·         Instructional Innovations, at , for instructional questions.

·         Regional Administrator, at (804) 782-4800, for questions regarding living donor policies.

·         UNet Help Desk, at (800) 978-4334 or , for technical questions.

Interested in additional instructional offerings? Please visit http://optn.transplant.hrsa.gov or http://transplantpro.org for more information.

 

 

ASHI Media and Public Relations Policy - Approved October 2014 | ASHI

News > ASHI Media and Public Relations Policy - Approved October 2014

ASHI Media and Public Relations Policy - Approved October 2014

Click here for the ASHI Media and Public Relations Policy - Approved October 2014

FOCIS 2015 | ASHI

News > FOCIS 2015

FOCIS 2015

Abstract submission and registration for the FOCIS 2015 meeting is open. Click here for more details.

Kidney Allocation System (KAS) Town Hall | ASHI

News > Kidney Allocation System (KAS) Town Hall

Kidney Allocation System (KAS) Town Hall

The Kidney Allocation System: Question and Answer Town Hall Recording Now Available

 

A recorded presentation of the Kidney Allocation System: Question and Answer Town Hall is now available. The recording lasts approximately 1 hour 2 minutes and can be accessed here.

 

As a follow-up to resources that have been provided to the community in preparation for implementation of the new kidney allocation system, a question and answer session with a panel of subject matter experts was offered to provide a venue for members to ask questions and to facilitate discussion for better understanding. The new kidney allocation system will be implemented on December 4, 2014.

 

Once you have viewed the recording, click here to access a brief evaluation. It will take less than 5 minutes to complete. We appreciate your feedback.

 

There were no continuing education credits offered for this town hall.

 

Additional information and resources on the new KAS can be found on the OPTN and Transplant Pro websites.

 

If you have any questions about educational offerings, please contact UNOS Instructional Innovations at .

UNOS requests your feedback | ASHI

News > UNOS requests your feedback

UNOS requests your feedback

 

The Instructional Innovations department at UNOS is interested in how you prefer to receive instructional offerings.

 

Please take a few minutes to scan the QR code and complete the survey from your mobile device.

 

QR

 

 

 

 

 

 

 

 

 

 

 

 

In the event you cannot access the QR code, try the following link to complete the survey:

https://www.surveymonkey.com/s/InstructionTypes.

 

 

 

 

 

 

 

 

 

 

 


 

 


New Recording Available from UNOS | ASHI

News > New Recording Available from UNOS

New Recording Available from UNOS

UNOS offers a new recording: "Applying the 2013 PHS Guideline for Reducing HIV, HBV, and HCV Transmission through Organ Transplantation to Donor Evaluations". The recording is approximately 28 minutes long. It is a two-part program. The second part of the recording begins at 14:14, in case individuals cannot listen to the entire recording in a single session. The recording can be accessed here: https://attendee.gotowebinar.com/recording/2378827853250106114

After viewing the recording, please complete an instructional evaluation via https://www.surveymonkey.com/s/PHS_Evaluation.

Additional resources on Applying the 2013 PHS Guideline for Reducing HIV, HBV, and HCV Transmission through Organ Transplantation to Donor Evaluations can be found on the OPTN website at http://optn.transplant.hrsa.gov/resources/patient-safety/.

To qualify to receive one CEPTC point, you must achieve a passing score on the post-instructional assessment. To pass, you can answer only one question incorrectly. You have multiple opportunities to take the test.

Once you have passed the assessment, your certificate will e-mailed to you within four to six weeks.

CEPTCs are available until April 14, 2015.

Access the assessment via https://www.surveymonkey.com/s/PHS_CEPTC_ASSESSMENT.

If you have questions, please contact:

  • Instructional Innovations, at , for instructional questions.
  • Regional Administrator, at (804) 782-4800, for questions regarding applying the 2013 PHS Guideline.
  • UNet Help Desk, at (800) 978-4334 or , for technical questions.

 

IMMUNOASSAYS WEBSITE | ASHI

News > IMMUNOASSAYS WEBSITE

IMMUNOASSAYS WEBSITE

IMMUNOASSAYS WEBSITE

In response to discussions at the 16th International Histocompatibility and Immunogenetics Workshop, members of the Johns Hopkins Immunogenetics Laboratory have created a website for all things related to solid phase antibody immunoassays.  At www.immunoassays.net, you can enter into discussions about test interpretation and troubleshooting. The site provides information on the latest assays, performance of different test lots, correlations between solid phase and cell based test results, and serum treatments.  There is information on bead assays, flow cytometry and ELISA as well as links to relevant publications. Please visit the website and become a member at www.immunoassays.net.  You can become a site moderator and lead discussions.  

 


New Instructional Resources from UNOS | ASHI

News > New Instructional Resources from UNOS

New Instructional Resources from UNOS

New Training Module Available to Educate Professionals and Patients about Kidney Allocation Changes

The national kidney allocation system (KAS) will be changing effective December 4, 2014. UNOS’s new KAS training module is our latest available tool to help educate both transplant professionals and patients waiting for a kidney transplant about the upcoming changes. Transplant professionals can use this module as a guide to talk to their patients about the upcoming changes and patients can also access it themselves to learn more about how the changes will impact them directly.

View module now

Program title: Introduction to the New Kidney Allocation System

Background: The current kidney matching system has helped tens of thousands of people get successful transplants.  But there are ways it can be further improved.  One issue was that some kidney recipients have not received a kidney that works as long as they may need.  Another issue was that some patients must wait much longer than others for a kidney due to their blood type or their immune response to most available kidneys. The revised system’s primary goal was to make the system better without making major changes to the parts of the system that work well.  The new system is expected to help more people have longer function with their transplanted kidney as well as to shorten the waiting time for some groups of kidney patients who often wait a very long time because they are hard to match with most kidneys.

Program Objectives: After completing this training module, you will be able to:

  • Describe changes to the kidney allocation system
  • Explain how system changes will impact kidney patients registered for transplant
  • Locate additional resources on kidney allocation policy

Audience: Kidney patients currently registered on the kidney transplant waiting list and kidney patients that will be registered for a kidney transplant after KAS is implemented.

Visit the OPTN and Transplant Pro websites for more relevant KAS instruction and materials.

 

Transplant Program Performance Monitoring Webinar

The Sept. 23 webinar describing Bayesian method for assessing transplant program performance has been recorded and archived for later reference.  The webinar provided additional information about the adoption of Bayesian methodology, compared it to previous methods of analysis, and summarized the likely impact of the new methodology on transplant programs with differing level of transplant volume.

Access webinar recording

View webinar slides

Visit the OPTN and Transplant Pro websites for more relevant quality-related instruction and materials.

Attention ASHI-Accredited Laboratories | ASHI

News > Attention ASHI-Accredited Laboratories

Attention ASHI-Accredited Laboratories

Please be aware of the following CMS approved ASHI Standards that are effective October 1, 2014.  The mandatory compliance date for the final rule regarding Patient Access to Test Reports is October 6, 2014.

Within the last several months, CMS published two Final Rules that affect CLIA.

1. Federal Register, Vol. 79, No. 25, CLIA Program and HIPAA Privacy Rule; Patients' Access to Test Reports; Final Rule.   HIPAA covered entities must comply with the applicable requirements of this final rule by October 6, 2014.  http://www.gpo.gov/fdsys/pkg/FR-2014-02-06/pdf/2014-02280.pdf

2. Federal Register, Vol. 79, No. 91, Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction; Part II.  Effective May 12, 2014.  http://www.gpo.gov/fdsys/pkg/FR-2014-05-12/pdf/2014-10687.pdf 

CMS-approved laboratory accreditation programs and CLIA-exempt State licensure programs must ensure that their requirements are updated to meet the regulation changes published in the Final Rules.  The Quality Assurance and Standards Committee (QAS) has been working on updates to the 2013 ASHI Standards to address these regulation changes.  These updates have been submitted to CMS and have been approved.  To assist you in maintaining your compliance, a crosswalk listing the applicable regulations and corresponding CMS approved ASHI Standards is provided here in Attachment A.  


Human Immunology is organizing a special issue on Single-Molecule Sequencing for Histocompatibility | ASHI

News > Human Immunology is organizing a special issue on Single-Molecule Sequencing for Histocompatibility

Human Immunology is organizing a special issue on Single-Molecule Sequencing for Histocompatibility

Human Immunology is organizing a special issue on Single-Molecule Sequencing for Histocompatibility and Immunogenetics. Editor in chief, Steve Mack, together with guest editors Dimitri Monos and Martin Maiers have prepared the Call for Papers that has been posted on the journal homepage at Elsevier.com.

 

http://www.journals.elsevier.com/human-immunology/call-for-papers/single-molecule-sequencing-for-histocompatibility-and-immuno/

 

 

CMS Gets Earful on Lab Testing Pricing, Methodology | ASHI

News > CMS Gets Earful on Lab Testing Pricing, Methodology

CMS Gets Earful on Lab Testing Pricing, Methodology

CMS Gets Earful on Lab Testing Pricing, Methodology

By Kimberly Scott, Managing Editor, G2 Intelligence

Industry stakeholders gathered in Baltimore July 14 to give officials at the Centers for Medicare and Medicaid Services (CMS) their recommendations on 2015 pricing for new and revised lab test codes, as well as payment methodology that will be use to revamp clinical lab pricing in future years.

 

There are more than 100 new and revised codes that will be on the 2015 Clinical Laboratory Fee Schedule (CLFS), many of them related to drug testing or genomic sequencing. Stakeholders, ranging from associations to labs to IVD companies, made recommendations to CMS on whether the new or revised codes should be gap-filled or cross-walked, and what existing codes would be most appropriate for cross-walking.

 

A few industry experts discussed methodologies for pricing new next-generation sequencing codes to be introduced in the 2015 CLFS. Commentary generally was focused on the complexity differences between panels (e.g., hotspot versus more comprehensive panels) and the resources that are involved in completing the assays. One speaker broke out the costs of performing a hotspot and non-hotspot panels (ranging from 5 to 50 genes), noting that hotspot panels are half the cost of more in-depth panels.

 

Participants also discussed the Protecting Access to Medicare Act of 2014 (PAMA), specifically the section titled "Improving Policies for Clinical Diagnostic Laboratory Tests." PAMA delays and provides limitations for implementation of annual CLFS cuts and ties Medicare reimbursement more closely to private payer reimbursement. The debate focused on managing what should be defined as an "applicable" lab (to keep representation broad while also keeping reporting and data requirements to a manageable level). Certain stakeholders suggested that if implemented as is, smaller labs would be at a disadvantage compared to larger labs because of economies of scale.

 

For more on the lab pricing meeting, see the next issue of National Intelligence Report.

The American Society for Microbiology (ASM) Administers 28 Achievement Awards | ASHI

News > The American Society for Microbiology (ASM) Administers 28 Achievement Awards

The American Society for Microbiology (ASM) Administers 28 Achievement Awards

The American Society for Microbiology (ASM) administers 28 achievement awards.  These are annual awards given at the ASM's two large meetings where scientists are honored for their outstanding accomplishments in research, mentoring, education, leadership, and other practices of microbiology.

More information on this award and the rest of the ASM's achievement awards can be found online at http://www.asm.org/awards.  

UNOS explains the basics of the new kidney allocation system | ASHI

News > UNOS explains the basics of the new kidney allocation system

UNOS explains the basics of the new kidney allocation system

In November 2013, the OPTN/UNOS Board of Directors approved policy to substantially revise the national kidney allocation system. The goal of this recorded webinar is to discuss fundamental changes in the kidney allocation policy and to provide OPTN members with specific information about tasks they need to complete to prepare them for implementation.
 
After viewing this webinar you will be able to:
 
1.         Explain the new kidney allocation policy and its goals.
2.         Summarize the changes in allocation components for deceased donor kidneys.
3.         Recognize the impact of the policy changes for kidney transplant programs, OPOs, and laboratories.
4.         Utilize tools and resources to prepare for policy implementation.
 
You may access the recording on the Organ Procurement and Transplantation (OPTN) website - http://optn.transplant.hrsa.gov/news/newsDetail.asp?id=1638 and on Transplant Pro http://transplantpro.org/kidney-allocation-system/. A frequently asked questions document has also been made available along with a checklist of actions to take to prepare kidney programs for implementation.
 
As a follow-up to “The New Kidney Allocation System: Basic Preparations” recorded webinar, a question and answer session with a panel of subject matter experts will be offered to provide an opportunity for members to ask questions to facilitate discussion and create a better understanding of the new kidney allocation system. Register now - https://attendee.gotowebinar.com/register/2861523348430594817.

Anthony Nolan has migrated its entire transplant data to the Cloud. | ASHI

News > Anthony Nolan has migrated its entire transplant data to the Cloud.

Anthony Nolan has migrated its entire transplant data to the Cloud.

This represents a significant step forward in the application of IT technology to the histocompatibility field.

Please click here for more information.

 

 

UNOS podcast on the New Kidney Allocation System available now | ASHI

News > UNOS podcast on the New Kidney Allocation System available now

UNOS podcast on the New Kidney Allocation System available now

The podcast recording entitled, “The New Kidney Allocation System: What Referring Physicians Need to Know” is now available on the Transplant Pro website.

 

http://transplantpro.org/introduction-new-kidney-allocation-system/

 

UNOS will provide resources that transplant professionals can use to help educate both their patients as well as other medical professionals who work in dialysis and treat kidney disease.  All resources will be available online as they are developed, including a brochure for patients explaining what will change.  A list of some of the professional education sessions that start later this month may be found through TransplantPro at:  http://transplantpro.org/education-on-the-new-kidney-allocation-system-is-a-focus-for-2014/.

 

If you have specific questions about the kidney allocation system, you may contact Regional Administration. For questions regarding education and training that will be provided, you may contact UNOS Instructional Innovations at  or call Kimberly Taylor, RN, Curriculum Development Instructor, at 804-782-4098.

 


Kidney Allocation System | ASHI

News > Kidney Allocation System

Kidney Allocation System

A focal point for UNOS this year is educating transplant and donation professionals about the changes coming to kidney allocation at the end of this year. The new kidney allocation policy was designed to improve outcomes for kidney recipients and increase the use of available kidneys.  The chair of the UNOS Policy Oversight Committee recently answered questions about the upcoming changes in this interview on her hospital’s blog.

 

UNOS will provide resources that transplant professionals can use to help educate both their patients as well as other medical professionals who work in dialysis and treat kidney disease.  All resources will be available online as they are developed, including a brochure for patients explaining what will change.  A list of some of the professional education sessions that start later this month may be found through TransplantPro at:  http://transplantpro.org/education-on-the-new-kidney-allocation-system-is-a-focus-for-2014/.

 

If you have specific questions about the kidney allocation system, contact your Regional Administrator. For questions regarding education and training that will be provided, you may contact UNOS Instructional Innovations at  or call Kimberly Taylor, Curriculum Development Instructor, at 804-782-4098.

 


ASHI and Elsevier welcome the new Human Immunology Editor-in Chief | ASHI

News > ASHI and Elsevier welcome the new Human Immunology Editor-in Chief

ASHI and Elsevier welcome the new Human Immunology Editor-in Chief

ASHI and Elsevier welcome the new Human Immunology Editor-in Chief, Dr. Steven Mack from Children's Hospital Oakland Research Institute. Dr. Mack has been an active and productive researcher in the histocompatibility and immunogenetics community for twenty years and an ASHI member for ten years. He has served on the editorial board of Human Immunology for six years and on the ASHI Scientific Affairs Committee for four years. Dr. Mack has been a reviewer for Human Immunology, as well as many other journals, for more than a decade. He is committed to advancing the field of immunogenetic research and to fostering the growth of ASHI as a basic and clinical research society, and will work to achieve these goals as Editor-in-Chief of Human Immunology.

Click here for more information.

 

Kidney Paired Donation Consensus Conference abstract | ASHI

News > Kidney Paired Donation Consensus Conference abstract

Kidney Paired Donation Consensus Conference abstract

A summary of the main conclusions from the March 29-30, 2012 Kidney Paired Donation Consensus Conference held in Herndon, Virginia, was recently published in the American Journal of Transplantation. Click here for the abstract. ASHI is pleased to be acknowledged in that publication as one of the “major contributors” and is also proud to note that several ASHI members are co-authors of the publication and that several additional ASHI members participated in the conference. This publication provides an important review of both the benefits and problems associated with the efforts of single-center and multi-center registries that facilitate the possibility for exchange donor kidney transplants for patients who otherwise would be unlikely to have transplants that quickly and to, thereby, increase the total number of transplants each year. It should be noted however, that some of the “consensus” conclusions from that conference are actually still controversial and no final recommendations can yet be made.

Government Relations | ASHI

News > Government Relations

Government Relations

ASHI has created an email address:

 

This will provide a mechanism for various government agencies to contact ASHI, however we also encourage our members to use this email address to report any government information obtained that would be of interest to ASHI members. Please feel free to forward this email address to any current government contacts you may have.


Official ruling on Vascularized Composite Allographs (VCA) | ASHI

News > Official ruling on Vascularized Composite Allographs (VCA)

Official ruling on Vascularized Composite Allographs (VCA)

The official VCA rule will be published in the Federal Register tomorrow. Click here to read it today!

Professional Societies Offer Recommendations Regarding Interim Pricing for Molecular Tests | ASHI

News > Professional Societies Offer Recommendations Regarding Interim Pricing for Molecular Tests

Professional Societies Offer Recommendations Regarding Interim Pricing for Molecular Tests

Over the last several months, ASHI partnered with the Association for Molecular Pathology (AMP) and other professional societies to formulate advocacy. This is in addition to the advocacy with CMS and Congress that these societies may be doing individually. The first activity of this group is the release of a consensus statement.

A press release and the coalition's consensus statement is available at here.

CMS' gapfill pricing and their stated rationale may be downloaded at the bottom of the web page here.

ASHI members who are FOCIS members can join the new FOCIS Community of Practice (COP) groups | ASHI

News > ASHI members who are FOCIS members can join the new FOCIS Community of Practice (COP) groups

ASHI members who are FOCIS members can join the new FOCIS Community of Practice (COP) groups

ASHI members who are FOCIS members can join the new FOCIS Community of Practice (COP) groups. FOCIS COPs are a new initiative created to give FOCIS Member Societies, like ASHI, a voice in scientific programming and to facilitate interdisciplinary cross-talk between societies.

Benefits of belonging to a COP include:

Scientific Program Participation – COP members will have the opportunity to submit sessions for consideration by the Annual Meeting Scientific Program Committee. These sessions could also be considered for Member Society Symposia at the Annual Meeting to highlight participating societies. Full descriptions of the roles and responsibilities are included in the COP membership form.

Leadership Opportunities – Join a COP(s) before April 15 to be considered for a leadership role. Chairs of each of the COPs will serve on the FOCIS Annual Meeting Program Committee. There are also roles for vice chairs and early career members on each COP Leadership Committee.

Interdisciplinary Career Enhancement – Think outside of the box with colleagues from different, but related disciplines. Find faster pathways and solutions to the issues you face on a daily basis. The following COPs were created based on the interests of the FOCIS Member Societies. You may join one or more of the following communities: 

·  Allergy

·  Immunology

·  Neuroscience

·  Laboratory Medicine/Environmental Sciences

·  GI/Rheumatology/Dermatology

·  Transplant/Genetics

·  Cancer

 COP participation is a benefit of FOCIS membership. For FOCIS membership information, click here.

1 millionth blood stem cell transplant marks major medical milestone | ASHI

News > 1 millionth blood stem cell transplant marks major medical milestone

1 millionth blood stem cell transplant marks major medical milestone

International cooperation among physicians, scientists credited for landmark achievement

Bern, Switzerland, Jan. 30, 2013—The collaborative work of medical scientists and physicians across the globe has resulted in a major medical milestone: the world’s 1 millionth blood stem cell transplant, a procedure that has become a proven and essential therapy for many patients battling blood cancers like leukemia and lymphoma, as well as other critical diseases.

The Worldwide Network for Blood and Marrow Transplantation (WBMT) announced the landmark achievement today. The WBMT—a nonprofit scientific organization whose mission is promoting excellence in stem cell transplantation, stem cell donation and cellular therapy—said the 1 millionth transplant occurred in late December 2012. The finding is based on data collected by WBMT international member organizationsinvolved in blood stem cell transplantation, which were analyzed and verified by the WBMT.

“One million transplants is a milestone that may surprise many people, because blood stem cell transplants were viewed as a rare procedure until the last decade or so,” said Dietger Niederwieser, M.D., president of the WBMT and professor of medicine in the division of hematology and medical oncology at the University Hospital of Leipzig, Germany. “But important discoveries—and the vital cooperation of many scientists and physicians around the world—have dramatically improved outcomes for patients who undergo stem cell transplantation.”

The first blood stem cell transplant was reported by Dr. E. Donnall Thomas in 1957, who received the Nobel Prize in 1990 for pioneering the use of this innovative approach to treatment of leukemia and other life-threatening diseases.

By the late 1960s, as knowledge of the requirements for matching patients with donors evolved, physicians were performing successful allogeneic transplants, using blood-forming stem cells from sibling donors (among the first in U.S., Holland and France). In 1973, the first successful transplant between two unrelated people occurred in New York, when a young boy received a transplant from a donor identified as a match through a blood bank in Denmark. In 1988, the first successful umbilical cord blood transplant was performed in Paris.

Since then, a near-exponential rise in all types of blood stem cell transplants, particularly from unrelated donors, has occurred. This is largely thanks to the willingness of now more than 20 million voluntary stem cell donors worldwide. Today, unrelated transplants are often as successful as those that use family donors.

For example, the U.S.-based National Marrow Donor Program (NMDP) – which operates the Be The Match Registry, the world’s largest and most diverse list of potential bone marrow donors and cord blood units – plans to double the number of unrelated transplants it facilitates annually in the near future.

International partners will help make this continued growth possible. Already, data from the World Marrow Donor Association (WMDA), a WBMT partner, show that nearly half of the transplants performed with unrelated donors cross an international border. International donor registries not only expand the pool of potential donors, they help advance the global science of transplantation through the exchange of information.

Founding partners of the WBMT include the Center for International Blood and Marrow Transplant Research® (CIBMTR), the Asia-Pacific Blood and Marrow Transplantation Group (APBMT), the European Group for Blood and Marrow Transplantation (EBMT) and the WMDA. Other regional and national organizations that participate and contribute data include the Australasian Bone Marrow Transplant Recipient Registry (ABMTRR), the Canadian Blood and Marrow Transplant Group (CBMTG), the Eastern Mediterranean Blood and Marrow Transplant Group (EMBMT) and the Sociedade Brasileira de Transplante de Medula Ossea (SBTMO), among others.

“It must be especially emphasized that WBMT has contributed to the advances of blood stem cell transplants in emerging countries in the Asia-Pacific region and in the other areas of the world, where the awareness to this medical procedure is sharply increasing,” said Yoshihisa Kodera, vice president of WBMT, chairman of APBMT and professor of Aichi Medical University, Japan.

The World Health Organization (WHO) has recognized transplantation as an important global task, recently recognizing the WBMT as a non-governmental organization (NGO). “Transplantation has extended the lifespan of hundreds of thousands of patients worldwide and enhanced their quality of life,” said Luc Noël, M.D., of WHO. “It has become the standard of care for many patients, and should no longer be restricted to affluent countries or individuals.”

Today, more than 70 malignant and non-malignant diseases are treated routinely with blood stem cell transplantation, providing new cures for patients around the globe. The procedure technique itself has improved considerably because of dedicated cancer centers but also because of collaboration and cooperation among scientists, clinicians, nurses and data managers, as well as the 19 international scientific societies that establish standards, collect data on the procedure and analyze outcomes. In patients with optimal conditions, disease-free survival rates are now reaching more than 90 percent.

“Worldwide, more than 50,000 patients a year are receiving transplants, in regions ranging from the Asia-Pacific to the Mid-East to Central America,” said Dennis Confer, M.D., treasurer of the WBMT and chief medical officer of the U.S.-based National Marrow Donor Program® (NMDP). “The curative potential of this therapy will only increase, thanks to the commitment and collaboration of researchers and physicians across the globe.”

About the Worldwide Network for Blood and Marrow Transplantation (WBMT)
The WBMT is a nonprofit, non-governmental organization (NGO) that promotes excellence in hematopoietic cell transplantation (HCT), stem cell donation and cellular therapy. It was created in 2006 by four pioneering stem cell transplantation groups from around the globe: the Center for International Blood and Marrow Transplant Research (CIBMTR), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), European Group for Blood and Marrow Transplantation (EBMT) and the World Marrow Donor Association (WMDA). With a current network of 19 member organizations worldwide, the WBMT is the leading voice among the stem cell transplantation community. Through its annual global survey of HCT activities, scientific and educational conferences, and the development of HCT guidelines and accreditations, the WBMT is advancing life-saving therapies that treat blood, immune system and genetic disorders. Learn more at http://www.wbmt.org.

About the World Health Organization (WHO)
WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.

 

WBMT Contacts:
Prof. Dietger Niederwieser; Tel. +49 341 97-13050; dietger(at)medizin.uni-leipzig.de
Prof. Yoshihisa Kodera; Tel.: +81 561 62 3311 (Ext. 2375); ykodera(at)river.ocn.ne.jp
Dennis Confer, MD; Tel: +1 612 362 3425; dconfer(at)nmdp.org

Media Contact:
Catherine Scott; Tel. +1 612 455 1719; cscott(at)padillaspeer.com


CPT Informational Page | ASHI

News > CPT Informational Page

CPT Informational Page

 

ASHI is pleased to provide this CPT Informational page for the convenience and education of the HLA community.  Please be aware that sometimes the links may have vendor or third party associations which ASHI neither supports nor promotes.  Registration may be required for access to related articles. ASHI is not responsible for emails received from the vendor or third party.  

http://www.ashi-hla.org/news/cptupdate/

 

If you have newsworthy information to add to the ASHI Web site, please contact kmiranda@ahint.com for consideration.

Corporate Supporters